{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:00:45Z","timestamp":1792040445064,"version":"4.4.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T00:00:00Z","timestamp":1235692800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1000321","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T22:56:09Z","timestamp":1235688969000},"page":"e1000321","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":217,"title":["Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man"],"prefix":"10.1371","volume":"5","author":[{"given":"Jean K.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Krysztof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Stramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid B.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,2,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1940.s1-20.471","article-title":"A neurotropic virus isolated from the blood of a native of Uganda.","volume":"20","author":"KC Smithburn","year":"1940","journal-title":"Am J Trop Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/313737","article-title":"The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience.","volume":"30","author":"DS Asnis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3201\/eid0505.990506","article-title":"West Nile fever\u2014a reemerging mosquito-borne viral disease in Europe.","volume":"5","author":"Z Hubalek","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.","volume":"286","author":"RS Lanciotti","year":"1999","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","article-title":"Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.","volume":"358","author":"F Mostashari","year":"2001","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","article-title":"West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States.","volume":"57","author":"EB Hayes","year":"2006","journal-title":"Annu Rev Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1128\/JVI.00489-06","article-title":"PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.","volume":"80","author":"MA Samuel","year":"2006","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biochi.2007.02.003","article-title":"The human 2\u2032\u20135\u2032oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2\u2032\u20135\u2032 instead of 3\u2032\u20135\u2032 phosphodiester bond formation.","volume":"89","author":"AG Hovanessian","year":"2007","journal-title":"Biochimie"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.","volume":"79","author":"MA Samuel","year":"2005","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/JVI.67.1.340-347.1993","article-title":"Genetic studies of flavivirus resistance in inbred strains derived from wild mice: evidence for a new resistance allele at the flavivirus resistance locus (Flv).","volume":"67","author":"MY Sangster","year":"1993","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/JVI.68.1.448-452.1994","article-title":"Mapping the Flv locus controlling resistance to flaviviruses on mouse chromosome 5.","volume":"68","author":"MY Sangster","year":"1994","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"11311","DOI":"10.1073\/pnas.172195399","article-title":"A nonsense mutation in the gene encoding 2\u2032\u20135\u2032-oligoadenylate synthetase\/L1 isoform is associated with West Nile virus susceptibility in laboratory mice.","volume":"99","author":"T Mashimo","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.142287799","article-title":"Positional cloning of the murine flavivirus resistance gene.","volume":"99","author":"AA Perelygin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0888-7543(03)00176-9","article-title":"Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2\u2032,5\u2032-oligoadenylate synthetases.","volume":"82","author":"T Mashimo","year":"2003","journal-title":"Genomics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/JVI.80.6.2987-2999.2006","article-title":"RNase L plays a role in the antiviral response to West Nile virus.","volume":"80","author":"SV Scherbik","year":"2006","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0022-2836(03)00055-X","article-title":"Differential action of natural selection on the N and C-terminal domains of 2\u2032\u20135\u2032 oligoadenylate synthetases and the potential nuclease function of the C-terminal domain.","volume":"326","author":"IB Rogozin","year":"2003","journal-title":"J Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1074\/jbc.M508649200","article-title":"The 2\u2032,5\u2032-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells.","volume":"281","author":"A Kajaste-Rudnitski","year":"2006","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1440-1711.2003.01166.x","article-title":"Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2\u2032\u20135\u2032 oligoadenylate synthetase 1b protein.","volume":"81","author":"M Lucas","year":"2003","journal-title":"Immunol Cell Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.virol.2007.08.017","article-title":"Knock-in of the Oas1b(r) allele into a flavivirus-induced disease susceptible mouse generates the resistant phenotype.","volume":"368","author":"SV Scherbik","year":"2007","journal-title":"Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection.","volume":"203","author":"WG Glass","year":"2006","journal-title":"J Exp Med"},{"key":"ref21","article-title":"Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile Virus infection: a meta-analysis of 4 cohorts in the US epidemic.","author":"JK Lim","year":"2007","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1086\/497340","article-title":"Single nucleotide polymorphisms in genes for 2\u2032\u20135\u2032-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.","volume":"192","author":"I Yakub","year":"2005","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/429391","article-title":"Variation in antiviral 2\u2032,5\u2032-oligoadenylate synthetase (2\u20325\u2032AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.","volume":"76","author":"V Bonnevie-Nielsen","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/PL00000644","article-title":"Gene structure and function of the 2\u2032\u20135\u2032-oligoadenylate synthetase family.","volume":"57","author":"J Justesen","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1537-2995.2006.00710.x","article-title":"Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors.","volume":"46","author":"SL Orton","year":"2006","journal-title":"Transfusion"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa044333","article-title":"West Nile virus among blood donors in the United States, 2003 and 2004.","volume":"353","author":"SL Stramer","year":"2005","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0039.2006.00694.x","article-title":"OAS1 gene haplotype confers susceptibility to multiple sclerosis.","volume":"68","author":"M Fedetz","year":"2006","journal-title":"Tissue Antigens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/diabetes.54.5.1588","article-title":"OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.","volume":"54","author":"LL Field","year":"2005","journal-title":"Diabetes"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/db05-1452","article-title":"No evidence for association of OAS1 with type 1 diabetes in unaffected siblings or type 1 diabetic cases.","volume":"55","author":"DJ Smyth","year":"2006","journal-title":"Diabetes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1128\/JVI.00316-07","article-title":"Early production of type i interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production.","volume":"81","author":"N Bourne","year":"2007","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virol.2005.01.021","article-title":"An infectious West Nile virus that expresses a GFP reporter gene.","volume":"334","author":"TC Pierson","year":"2005","journal-title":"Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1537-2995.2006.00769.x","article-title":"Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.","volume":"46","author":"M Rios","year":"2006","journal-title":"Transfusion"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6101(00)00027-7","article-title":"The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion.","volume":"12","author":"DE Levy","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses.","volume":"79","author":"JL Munoz-Jordan","year":"2005","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.bbrc.2005.02.101","article-title":"Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population.","volume":"329","author":"E Hamano","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2334-6-106","article-title":"Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.","volume":"6","author":"J He","year":"2006","journal-title":"BMC Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.gene.6363984","article-title":"Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.","volume":"4","author":"S Knapp","year":"2003","journal-title":"Genes Immun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2710.2006.00761.x","article-title":"2\u2032-,5\u2032-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.","volume":"31","author":"KI Kim","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1096-9071(200010)62:2<185::AID-JMV9>3.0.CO;2-X","article-title":"Effect of interferon treatment on serum 2\u2032,5\u2032-oligoadenylate synthetase levels in hepatitis C-infected patients.","volume":"62","author":"S Murashima","year":"2000","journal-title":"J Med Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/427945","article-title":"Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.","volume":"40","author":"AC Kalil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1592\/phco.27.3.455","article-title":"Successful treatment of West Nile virus infection after approximately 3 weeks into the disease course.","volume":"27","author":"M Lewis","year":"2007","journal-title":"Pharmacotherapy"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1080\/00365540500262690","article-title":"Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis.","volume":"37","author":"KM Chan-Tack","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03401665","article-title":"Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.","volume":"3","author":"PA Zimmerman","year":"1997","journal-title":"Mol Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/nm1295-1320","article-title":"Infection of human tonsil histocultures: a model for HIV pathogenesis.","volume":"1","author":"S Glushakova","year":"1995","journal-title":"Nat Med"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1000321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T05:37:05Z","timestamp":1589607425000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1000321"}},"subtitle":[],"editor":[{"given":"Charles M.","family":"Rice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,2,27]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1000321","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,27]]}}}